Seattle Genetics, Inc. (SGEN): Price and Financial Metrics


Seattle Genetics, Inc. (SGEN)

Today's Latest Price: $110.43 USD

3.14 (-2.76%)

Updated Jan 27 4:39pm

Add SGEN to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 340 in Biotech

See all "A" rated Strong Buy stocks

SGEN Stock Summary

  • With a market capitalization of $18,278,280,212, Seattle Genetics Inc has a greater market value than 89.69% of US stocks.
  • SGEN's price/sales ratio is 22.81; that's higher than the P/S ratio of 94.49% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.2 for Seattle Genetics Inc; that's greater than it is for only 11.42% of US stocks.
  • If you're looking for stocks that are quantitatively similar to Seattle Genetics Inc, a group of peers worth examining would be SWKS, STX, HALO, XLNX, and BLUE.
  • Visit SGEN's SEC page to see the company's official filings. To visit the company's web site, go to www.seattlegenetics.com.
SGEN Daily Price Range
SGEN 52-Week Price Range

SGEN Stock Price Chart More Charts


SGEN Price/Volume Stats

Current price $110.43 52-week high $122.36
Prev. close $113.57 52-week low $62.90
Day low $108.87 Volume 1,013,706
Day high $112.52 Avg. volume 1,026,256
50-day MA $114.19 Dividend yield N/A
200-day MA $85.77 Market Cap 18.93B

Seattle Genetics, Inc. (SGEN) Company Bio


Seattle Genetics is a biotechnology company focused on the development and commercialization of innovative antibody-based therapies for the treatment of cancer. The company was founded in 1998 and is based in Bothell, Washington.





SGEN Latest News Stream


Event/Time News Detail
Loading, please wait...

SGEN Latest Social Stream


Loading social stream, please wait...

View Full SGEN Social Stream

SGEN Price Returns

1-mo -2.64%
3-mo 4.94%
6-mo 45.86%
1-year 51.81%
3-year 88.80%
5-year 247.92%
YTD -3.35%
2019 101.66%
2018 5.91%
2017 1.38%
2016 17.58%
2015 39.68%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6665 seconds.